TY - JOUR
T1 - Resistance to the quorum-quenching compounds brominated furanone C-30 and 5-fluorouracil in Pseudomonas aeruginosa clinical isolates
AU - García-Contreras, Rodolfo
AU - Martínez-Vázquez, Mariano
AU - Velázquez Guadarrama, Norma
AU - Villegas Pañeda, Alejandra Guadalupe
AU - Hashimoto, Takahiro
AU - Maeda, Toshinari
AU - Quezada, Héctor
AU - Wood, Thomas K.
PY - 2013/6
Y1 - 2013/6
N2 - The quorum-quenching compounds brominated furanone C-30 and 5-fluorouracil inhibit the pathogenicity of the Pseudomonas aeruginosa laboratory strains PA01 and PA14; however, there is no report studying the effectiveness of these compounds for clinical isolates. Therefore, the effect of both quorum quenchers on the production of pyocyanin, elastase and alkaline protease of eight clinical strains from children was evaluated. Although both compounds were in general effective for the attenuation of these factors, three strains resistant to C-30 were found. For 5-fluorouracil, PA01 and some clinical isolates showed resistance for at least one phenotype. In this work the effect of 2 quorum sensing inhibitors on different clinical isolates of Pseudomonas aeruginosa was examined and some of the isolates were found to be resistant the inhibitors. The results are potentially useful for the clinic and for treatment of P. aeruginosa infections.
AB - The quorum-quenching compounds brominated furanone C-30 and 5-fluorouracil inhibit the pathogenicity of the Pseudomonas aeruginosa laboratory strains PA01 and PA14; however, there is no report studying the effectiveness of these compounds for clinical isolates. Therefore, the effect of both quorum quenchers on the production of pyocyanin, elastase and alkaline protease of eight clinical strains from children was evaluated. Although both compounds were in general effective for the attenuation of these factors, three strains resistant to C-30 were found. For 5-fluorouracil, PA01 and some clinical isolates showed resistance for at least one phenotype. In this work the effect of 2 quorum sensing inhibitors on different clinical isolates of Pseudomonas aeruginosa was examined and some of the isolates were found to be resistant the inhibitors. The results are potentially useful for the clinic and for treatment of P. aeruginosa infections.
UR - http://www.scopus.com/inward/record.url?scp=84886686961&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84886686961&partnerID=8YFLogxK
U2 - 10.1111/2049-632X.12039
DO - 10.1111/2049-632X.12039
M3 - Article
C2 - 23620228
AN - SCOPUS:84886686961
SN - 2049-632X
VL - 68
SP - 8
EP - 11
JO - Pathogens and disease
JF - Pathogens and disease
IS - 1
ER -